NCT01740037 IntegRAted Chronic Care Program at Specialized AF Clinic Versus Usual CarE in Patients With Atrial Fibrillation - RACE4 Status COMPLETED Phase NA
NCT01739127 Comparison of Aripiprazole Versus Higher Metabolic Risk Antipsychotic Drugs on Adiposity Using MRI Status COMPLETED Phase N/A
NCT01737047 The Effects of Ageing on the 'Pharmacokinetic and Clinical Observations in People Over Fifty' Status COMPLETED Phase N/A
NCT01732848 A Follow-up Evaluation for Safety in Subjects Who Participated in a Phase 1 Study With BMS-986094 (INX-08189) Status COMPLETED Phase N/A
NCT01730534 Multicenter Trial to Evaluate the Effect of Dapagliflozin on the Incidence of Cardiovascular Events Status COMPLETED Phase PHASE3
NCT01726439 Effectiveness of Nucleos(t)Ide Analogs (NUC) Therapy Among Naive CHB Patients in China Status COMPLETED Phase N/A
NCT01725542 Pilot Study to Assess the Efficacy of and Tolerance to a QUadruple Therapy to Treat HIV-HCV Coinfected Patients Previously Null Responders Status COMPLETED Phase PHASE2
NCT01721772 Study of Nivolumab (BMS-936558) Compared With Dacarbazine in Untreated, Unresectable, or Metastatic Melanoma Status COMPLETED Phase PHASE3
NCT01721759 Study of Nivolumab (BMS-936558) in Patients With Advanced or Metastatic Squamous Cell Nonsmall-cell Lung Cancer Who Have Received At Least 2 Prior Systemic Regimens Status COMPLETED Phase PHASE2
NCT01721746 A Study to Compare BMS-936558 to the Physician's Choice of Either Dacarbazine or Carboplatin and Paclitaxel in Advanced Melanoma Patients That Have Progressed Following Anti-CTLA-4 Therapy (CheckMate 037) Status COMPLETED Phase PHASE3
NCT01718158 Efficacy and Safety Evaluation of a Regimen Consisting of Peginterferon Lambda-1a + Ribavirin + Daclatasvir (Lambda + RBV + DCV) in HCV Genotype 1b Treatment naïve Patients or Prior Relapsers to Peginterferon Alfa + Ribavirin (Alfa + RBV) Therapy Status COMPLETED Phase PHASE3
NCT01718145 A Phase 3, Comparative Study of Asunaprevir and Daclatasvir Combination Therapy Versus Telaprevir Therapy in Japanese HCV Subjects Status COMPLETED Phase PHASE3
NCT01717846 Effect on Orencia (Abatacept) on the Apoptosis of T Cells, B Cells and APC Cells in Rheumatoid Arthritis Status WITHDRAWN Phase PHASE4
NCT01716806 A Study of Brentuximab Vedotin With Hodgkin Lymphoma (HL) and CD30-expressing Peripheral T-cell Lymphoma (PTCL) Status COMPLETED Phase PHASE2
NCT01714817 Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis Status TERMINATED Phase PHASE3
NCT01714739 A Study of an Anti-KIR Antibody Lirilumab in Combination With an Anti-PD1 Antibody Nivolumab and Nivolumab Plus an Anti-CTLA-4 Ipilimumab Antibody in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT01709162 Study to Compare the Effect of Ipilimumab Retreatment With That of Chemotherapy in Advanced Melanoma Status TERMINATED Phase PHASE2
NCT01708889 Pharmacokinetic Study of BMS-914143 in Participants With Normal Renal Function and Mild, Moderate, Severe and End-stage Renal Dysfunction Status COMPLETED Phase PHASE1
NCT01707394 Study to Evaluate a Single Dose of Apixaban in Pediatric Participants at Risk for a Thrombotic Disorder Status COMPLETED Phase PHASE1
NCT01703507 Phase I Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma Status COMPLETED Phase PHASE1